Orange Book product · Generic (ANDA)
CARMUSTINE
CARMUSTINE
At a glance
Sep 11, 2018
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 11, 2018
7 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
CARMUSTINE
Strength
100MG/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 210179
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CARMUSTINE
- 2022CARMUSTINEBrand (NDA)
NDA 215000 · ACCORD HLTHCARE
- 1996GLIADELBrand (NDA)
NDA 020637 · AZURITY
- —BICNUBrand (NDA)
NDA 017422 · AVET LIFESCIENCES
- 2023CARMUSTINEGeneric (ANDA)
ANDA 215730 · ALEMBIC
- 2023CARMUSTINEGeneric (ANDA)
ANDA 214814 · MSN
- 2023CARMUSTINEGeneric (ANDA)
ANDA 215368 · PHARMOBEDIENT
- 2022CARMUSTINEGeneric (ANDA)
ANDA 214117 · ACCORD HLTHCARE
- 2022CARMUSTINEGeneric (ANDA)
ANDA 211011 · INGENUS PHARMS LLC
- 2021CARMUSTINEGeneric (ANDA)
ANDA 213460 · MEITHEAL
- 2021CARMUSTINEGeneric (ANDA)
ANDA 211202 · HENGRUI PHARMA
- 2020CARMUSTINEGeneric (ANDA)
ANDA 213207 · DR REDDYS
- 2019CARMUSTINEGeneric (ANDA)
ANDA 209278 · PENN LIFE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
